Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Protocols 022, 025, 029)

NCT01286207 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01286207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01286207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Protocols 022, 025, 029)
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1995
Completion date
May 31, 1997
Enrollment
1,959 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders